Recent Headlines
AdvantaPure(R) Releases Its Schedule of Trade Show Appearances for Summer and Fall 2016; Includes Events in the US and Asia
AdvantaPure, the high-purity division of plastic tubing manufacturer NewAge Industries, will exhibit at shows in Taiwan, Massachusetts and China over the next several months. The shows will focus on biopharmaceutical and pharmaceutical equipment and processes. AdvantaPure will highlight its products that meet those processing needs, such as Single-Use tubing, process hose, leak-proof molded manifold assemblies, container closures, and wall pass-through systems. - July 15, 2016 - AdvantaPure
Alfa Scientific Designs, Inc. to Introduce New Products and Driven Flow™ Technology During Exhibition Events in August
Alfa Scientific Designs, Inc., a leader in the development and manufacture of rapid immunoassay point-of-care tests, will be introducing its newest products featuring Driven Flow™ Technology during August at summer tradeshow events across the U.S. While attending the 68th American Association... - July 13, 2016 - Alfa Scientific Designs
A Connected Care Management Strategy to Reduce Readmissions and Avoidable Emergency Department Visits: an AMITA Health Case Study on August 2, 2016
AMITA Health will outline the connected care management strategy that provides the backbone for care coordination within AMITA's clinically integrated network and ACO during an August 2, 2016 webinar sponsored by the Healthcare Intelligence Network. - July 11, 2016 - Healthcare Intelligence Network
Saffa Compounding Pharmacy/Sunshine Care Partners Tulsa. Saffa Pharmacy Announced as Sunshine Care Partners Territory License Owner for Tulsa County, OK.
Saffa Compounding Pharmacy is proud to announce its purchase of the Sunshine Care Partners, Tulsa County Territory, and welcomes territory owners Debra Wells DPh, and Karla Taylor, both residents of Tulsa County. Tulsa County physicians serving Chronic Care Patients can partner with Saffa/Sunshine who, after serving the community for over 42 years, is expanding their services to both physicians and patients. - July 07, 2016 - Saffa Compounding Pharmacy
Top U.S. Hospital to Share Tactics for Targeting High-Risk and Rising-Risk Patients During August 1, 2016 Webinar
Massachusetts General Hospital, ranked number one in the nation by U.S. News & World Report®, will outline its population health approach to targeting high-risk and risking-risk patients during an August 1, 2016 webinar sponsored by the Healthcare Intelligence Network. - July 06, 2016 - Healthcare Intelligence Network
Natural Killer Cells - Competitive Landscape, Technology and Pipeline Analysis, 2016
The report provides information on the therapeutic development based on the Natural Killer Cells across 35+ pipeline drugs and 20+ companies active in this field. DelevInsight's Report also provides the comparative analysis of Natural Killer Cells at various stages of development like... - July 01, 2016 - DelveInsight
Organic Solution Management LLC. Helps Partner Win EPA Sustainability Award Using Organic Solution Management’s Sustainable Anaerobic Digestion Program
Organic Solution Management helps partner, Crystal Creamery, a Modesto-based dairy, win a Sustainability Award from the Environmental Protection Agency (EPA) for sustainable management of organic by-products and water reduction. - June 29, 2016 - Organic Solution Management
Alfa Scientific Designs, Inc. Issued Patent for Driven Flow™ Technology
Patent covers new, high-accuracy diagnostic tool that delivers testing results in seconds. - June 28, 2016 - Alfa Scientific Designs
July 14, 2016 Webinar: The New Physician Quality Reporting: Positioning Your Practice for MACRA's Merit-Based Incentive Payment System
McKesson will chart the sea change in physician payments under MACRA and advise physician practices on tactics to maximize MIPS reimbursement in 2017 during a July 14, 2016 webinar sponsored by the Healthcare Intelligence Network. - June 23, 2016 - Healthcare Intelligence Network
Diabetic Nephropathy - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Diabetic Nephropathy - Pipeline Insights, 2016 to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight. In addition to this their research expertise provides their clients with up to date information of market till date order has been placed. - June 23, 2016 - DelveInsight
Tabula Rasa HealthCare Subsidiary Medliance Promotes Rebstock to Executive Director
TRHC Chairman and CEO Calvin H. Knowlton named Candy Rebstock Executive Director of its wholly-owned subsidiary, Medliance, which is the leading pharmacy cost management solution for post-acute care. Clients rely on Medliance's adjudication and consulting services to create transparency and increase communication between client skilled nursing facilities and their pharmacy partners. - June 20, 2016 - Tabula Rasa HealthCare
Ovarian Cancer - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Ovarian Cancer - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - June 19, 2016 - DelveInsight
ElectroCore’s Non-Invasive Vagus Nerve Stimulation (nVNS) Demonstrates Efficacy in Preventing Cluster Headache and Menstrual Migraine
The results of two studies, presented at the American Headache Society (AHS) Science Meeting last weekend in San Diego, show that using electroCore’s non-invasive vagus nerve stimulation (nVNS) therapy, gammaCore®, is effective at preventing both cluster headache and menstrual migraine. - June 17, 2016 - electroCore
Estrogen Receptor Positive (ER+) Breast Cancer - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added a new report Estrogen Receptor Positive (ER+) Breast Cancer - Pipeline Insights, 2016 to its portfolio. - June 17, 2016 - DelveInsight
AdvantaPure(R) Offers a New White Paper Focusing on Molded Tubing Connections; Illustrates the Risks and Expenses of Fluid Leaks in Biopharma Manufacturing Operations
Immediately available from high purity tubing manufacturer AdvantaPure is a report titled “How Molded Manifold Assemblies Prevent Leaks and Costly Consequences.” It addresses the risks and costs associated with tubing-to-fitting connection leaks and presents a solution, namely the use of molded connections. The white paper shows how critical leak risk becomes based on the number of connections in a manifold assembly. Additional white papers are available as well. - June 16, 2016 - AdvantaPure
ValueTrak 8.0 Release Re-Imagines Fee-for-Service Scorecarding with New Data Quality Metrics and Robust Customization Capabilities
ValueCentric, the industry leader in healthcare channel intelligence, announced enhancements to their Scorecard capabilities as part of ValueTrak 8.0 software release. Improvements include advanced Specialty and Channel Data Management metrics, integrating data completeness, timeliness, and... - June 15, 2016 - ValueCentric
South Korea Patent Allowance for Anti-Obesity Pet Vaccines to Braasch Biotech LLC
Braasch Biotech granted Anti-Obesity patent for pets by Korean Intellectual Property Office. Commercial utility and novelty for first therapeutic vaccine for use in obese dogs, cats and horses. - June 11, 2016 - Braasch Biotech LLC
Seven Presentations on electroCore’s Treatment for Cluster Headache and Migraine Will Feature at American Headache Society Science Meeting
Recent clinical and preclinical results using electroCore’s non-invasive vagus nerve stimulation (nVNS, gammaCore®) therapy in the treatment and prevention of primary headache are the subject of seven presentations at the American Headache Society (AHS) Science Meeting being held at San... - June 08, 2016 - electroCore
ALPCO Releases New Broad Range Periostin ELISA
ALPCO now has a new broad range Periostin ELISA capable of measuring elevated levels of periostin consistent with current research. - June 07, 2016 - ALPCO
June 30, 2016 Webinar: Behavioral Health Patient Engagement: Using Motivational Interviewing to Improve Outcomes
The latest applications of motivational interviewing to engage individuals with behavioral health issues will be explored during a June 30, 2016 webinar on Behavioral Health Patient Engagement sponsored by the Healthcare Intelligence Network. - June 06, 2016 - Healthcare Intelligence Network
Tabula Rasa HealthCare CEO Calvin H. Knowlton Named Technology CEO of the Year
Tabula Rasa HealthCare Chairman and CEO, Calvin H. Knowlton, received the 2016 PACT Enterprise Award for Technology CEO of the Year at a gala event in Philadelphia, May 12. While accepting the award, Knowlton stated, "TRHC results include enhanced medication-related outcomes and greater operational efficiency. The work we are doing in medication informatics, personalized medication management, and compliance/assurance is exciting and, we believe, game changing." - June 03, 2016 - Tabula Rasa HealthCare
Head and Neck Squamous Cell Carcinoma - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added a new report, "Head and Neck Squamous Cell Carcinoma - Pipeline Insights, 2016" to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight. - June 02, 2016 - DelveInsight
Theater Slim PCR Cycler - Small Footprint, Small Price, Great Flexibility
MoBiTec is selling an incredibly small, light, and slim (4 cm), yet fully functional PCR instrument - The Theater Slim PCR Cycler. It is beneficial to small-sized labs and in-the-field research. - June 01, 2016 - MoBiTec GmbH
Makers Nutrition Receives Nine Stevie® Awards in 2016 American Business Awards
Makers Nutrition and other Stevie winners will be presented with their awards on June 20th in New York. - May 26, 2016 - Makers Nutrition, LLC
Pancreatic Cancer - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Pancreatic Cancer - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - May 26, 2016 - DelveInsight
MoBiTec GmbH Teams Up with TargetMol, US, to Offer Thousands of Inhibitors and Predetermined Screening Libraries
TargetMol supplies over 3000 compounds used in the study of cell signaling pathways and drug discovery. TargetMol provides more than 32 types of compound libraries, available for cell induction, signaling pathway, and high-throughput screening (HTS). - May 25, 2016 - MoBiTec GmbH
BÜHLMANN Laboratories AG Announces New Health Canada License for the BÜHLMANN fCAL® turbo Assay
BÜHLMANN Laboratories AG's immunoturbidimetric assay for fecal calprotectin quantification, BÜHLMANN fCAL® turbo is now commercially available in Canada and is Health Canada licensed. - May 24, 2016 - BUHLMANN Diagnostics Corp
In 2016 Population Health Metrics, Risk-Based Payment Models Shift Scrutiny to "Rising Risk"
New population health management metrics from the Healthcare Intelligence Network (HIN) indicate that healthcare organizations are doubling down on the "rising risk" - individuals with two or more unmanaged health conditions - to maximize value-based reimbursement. - May 24, 2016 - Healthcare Intelligence Network
ValueCentric’s Training Conference, Focus 2016, Sells-Out in Record Time
ValueCentric, the leader in healthcare channel intelligence, today announced their annual user-training conference, being held in Princeton, NJ May 24th and 25th, has sold out. Anticipation for this event has accelerated with the company’s expanded data service offerings, a significant... - May 20, 2016 - ValueCentric
Now Available: A Red-Fluorescent cADDis Assay Kit, Manufactured by Montana Molecular, for Measuring cAMP Changes in Live Mammalian Cells
Cyclic AMP (cAMP) is the prototypical second messenger. The major receptor in eukaryotic cells, cAMP-dependent Protein Kinase (PKA), is ubiquitous. cAMP affects many different physiological and biochemical processes, including the activity of kinases. In contrast to the hitherto available green-fluorescent cADDis kit, the red-fluorescent counterpart can be used in combination with green-fluorescent gene constructs, such as GFP, or ion indicators. - May 19, 2016 - MoBiTec GmbH
electroCore's GammaCore is Both Effective and Cost Effective for the Treatment of Cluster Headache
A paper in the Journal of Headache and Pain reports that non-invasive stimulation of the vagus nerve (nVNS) is a cost effective therapy for cluster headache. These findings were based on reductions in medication use and improvements in quality of life. The publication also notes that further... - May 18, 2016 - electroCore
DelveInsight's Latest Release: Acute Ischemic Stroke - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added a new report Acute Ischemic Stroke - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - May 17, 2016 - DelveInsight
Lysosomal Storage Disorder - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Lysosomal Storage Disorder - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - May 14, 2016 - DelveInsight
Antibody Drug Conjugate Insight: Technology Trend, Pipeline Assessment and Competitive Landscape, 2016
DelveInsight has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its Portfolio. - May 14, 2016 - DelveInsight
Anticoagulants-Market Insights & Drugs Sales Forecast (VTE & AF)-2020 - A DelveInsight Report
According to DelveInsight researchers, the Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 2020 growing at a CAGR of 8.59% from 2015 to 2020. - May 12, 2016 - DelveInsight
Careington Attends Transatlantic Business Conference
Careington International Corporation CEO Barbara Williams will be attending the British American Business Council (BABC) annual Transatlantic Business Conference in London on May 11 and 12, 2016. Attending with Williams will be Bruce Bernstein, Assistant Vice President of Global Sales Development with Careington’s UK affiliate Munroe Sutton, and Head of Munroe Sutton’s Business Development division, Robert Malvasi. - May 11, 2016 - Careington
Obsessive Compulsive Disorder (OCD) - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Obsessive Compulsive Disorder (OCD) - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed. - May 11, 2016 - DelveInsight
Makers Nutrition Launches Stock Softgels Brand
Nutraceutical Company Powers Softgel Products to Vitamin and Supplement Businesses - May 10, 2016 - Makers Nutrition, LLC
3097 Pounds Shed by Minnesotans in the Slim Down Challenge; Winners Announced
The Slim Down Challenge, hosted by Seattle Sutton’s Healthy Eating (SSHE) of Minnesota, was a 16-week challenge for participants to improve their health and lose weight through their nutrition. Over 300 Minnesotans entered the Challenge, with 81 of them completing the full 16-week period, losing a total of 3097 pounds, and achieving substantial improvements in their health metrics as a result. - May 05, 2016 - Seattle Sutton's Healthy Eating
The Morgan Leary Vaughan Fund Honors Dr. Edmund F. La Gamma
The Morgan Leary Vaughan Fund honored Edmund F. La Gamma, MD, Chief, Newborn Medicine at Maria Fareri Children's Hospital, a Member of the Westchester Medical Center Health Network, with the inaugural Lily Pedro Award for Excellence. The event, The 1st Annual Morgan's FunDay, was held at the... - May 05, 2016 - The Morgan Leary Vaughan Fund, Inc.
RuCor Strategies LLC Announces the Launch of CamCare, the First National Membership Benefit Reimbursement Program for Complementary Alternative Medicine Services
Designed membership plans help consumers pay for complementary alternative medicine visits. - May 04, 2016 - RucorStrategies, LLC / Camcare
NJHA Brings Medication Risk Mitigation Services to New Jersey Hospitals Through Strategic Alliance with Tabula Rasa HealthCare
New Jersey Hospital Association and Tabula Rasa HealthCare (TRHC) have entered into a 3-year agreement to offer TRHC's proprietary Medication Risk Mitigation™ products and services to NJHA’s nearly 400 member healthcare organizations. - May 02, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare Names Kristen Propp Creative Director; Healthcare Technology Company Expands Marketing Heft with New Hire
Tabula Rasa HealthCare, Inc. (TRHC) President Orsula V. Knowlton announced graphic designer, Kristen Propp, has joined the healthcare technology company as Creative Director. TRHC is a leader in providing patient-specific, data-driven technology and solutions for health care organizations. - May 02, 2016 - Tabula Rasa HealthCare
Sentynl Therapeutics, Inc. Acquires Abstral®
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it acquired the rights to market Abstral® in the U.S. from Galena Biopharma. Abstral® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentnyl Therapeutics, Inc. Re-Launches Abstral® in the United States
Sentynl Therapeutics, Inc. (“Sentynl”) announced that its commercial organization relaunched Abstral® in the United States. Sentynl acquired the rights to market Abstral® from Galena Biopharma in November 2015. Abstral® is indicated for the management of breakthrough pain... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Welcomes Darren Pincus as Vice President of Business Development
Sentynl Therapeutics, Inc. (“Sentynl”) announced that Darren Pincus joined Sentynl as its Vice President and head of Business Development. Mr. Pincus is a highly experienced business development professional with a strong track record of successfully completed transactions. Prior to... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Launches Sentynl Patient Services
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it launched Sentynl Patient Services to enhance patient access to its products. Sentynl Patient Services provides support to patients who want assistance with investigating their benefits, affording their medications and locating... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Launches Its Commercial Organization
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it launched its commercial organization including a full-time, professional sales force of key account specialists. About Sentynl Therapeutics. Sentynl provides healthcare professionals with treatment solutions that enable them to... - April 30, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Welcomes Michael Hercz as Its Senior Vice President and General Counsel
Sentynl Therapeutics, Inc. (“Sentynl”) announced that Michael Hercz joined Sentynl as its Senior Vice President, General Counsel and Chief Compliance Officer. Mr. Hercz brings more than 18 years of legal, compliance and risk management experience to Sentynl. Prior to Sentynl, Mr. Hercz... - April 30, 2016 - Sentynl Therapeutics, Inc.
Compounding Pharmacy Supplies Medication for Study Using Edetate Disodium Therapy
Following the generally positive outcome of the National Institutes of Health-funded Trial to Assess Chelation Therapy (TACT)[1] study completed in 2012, it was decided that further research was warranted to test the safety and effectiveness of Chelation therapy as a treatment option for... - April 27, 2016 - Universal Arts Compounding Pharmacy